ONDANSETRON HYDROCHLORIDE

ONDANSETRON HYDROCHLORIDE was reported 125108 times

ONDANSETRON HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 APPENDICOLITH 297 0.7674
1 SLEEP DISORDER THERAPY 151 0.7626
2 ANTACID THERAPY 94 0.7231
3 LYMPHOID TISSUE HYPOPLASIA 88 0.5752
4 THYMUS HYPOPLASIA 86 0.4943
5 ANALGESIC THERAPY 153 0.4766
6 DRUG THERAPY 139 0.4100
7 ANTICOAGULANT THERAPY 96 0.3380
8 LEFT-TO-RIGHT CARDIAC SHUNT 93 0.3153
9 NEUROLOGIC NEGLECT SYNDROME 172 0.3094
10 CAROTID ARTERY THROMBOSIS 183 0.2155
11 DISSEMINATED ASPERGILLOSIS 92 0.1949
12 ADJUSTMENT DISORDER 180 0.1385
13 TEMPERATURE REGULATION DISORDER 305 0.1368
14 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 142 0.1337
15 HYPERPHOSPHATAEMIA 236 0.1097
16 APLASTIC ANAEMIA 540 0.1033
17 NEPHROGENIC ANAEMIA 470 0.1014
18 BLOOD PHOSPHORUS INCREASED 259 0.0948
19 HYPERPARATHYROIDISM SECONDARY 229 0.0913
20 FEBRILE NEUTROPENIA 4942 0.0744
21 REBOUND ACID HYPERSECRETION 215 0.0710
22 PLATELET TRANSFUSION 90 0.0699
23 FOETAL DEATH 361 0.0695
24 PERSONALITY DISORDER 178 0.0679
25 INFUSION SITE DISCHARGE 119 0.0678
26 FOOD ALLERGY 485 0.0628
27 NEUTROPENIC SEPSIS 442 0.0618
28 TORSADE DE POINTES 483 0.0615
29 NEUTROPENIC COLITIS 124 0.0599
30 HEART DISEASE CONGENITAL 201 0.0568
31 FEBRILE BONE MARROW APLASIA 235 0.0552
32 LONG QT SYNDROME 129 0.0537
33 VENTRICULAR FIBRILLATION 596 0.0536
34 OCULOGYRIC CRISIS 114 0.0531
35 SEROTONIN SYNDROME 1003 0.0522
36 APLASIA 102 0.0520
37 TOTAL LUNG CAPACITY DECREASED 83 0.0519
38 END STAGE RENAL DISEASE 941 0.0515
39 VASCULAR DEVICE INFECTION 232 0.0511
40 PSEUDOMONAL SEPSIS 89 0.0508
41 CLONUS 136 0.0497
42 HYPOPHOSPHATAEMIA 343 0.0464
43 CYTOKINE RELEASE SYNDROME 899 0.0448
44 PLEURITIC PAIN 121 0.0438
45 DEVICE INFUSION ISSUE 108 0.0435
46 LUNG OPACITY 112 0.0425
47 IRON DEFICIENCY 191 0.0424
48 APPENDICITIS 390 0.0417
49 INFUSION SITE HAEMORRHAGE 137 0.0416
50 MUCOSAL INFLAMMATION 1085 0.0414
51 STRIDOR 121 0.0411
52 LARYNGOSPASM 109 0.0405
53 INFUSION SITE BRUISING 86 0.0398
54 ESCHERICHIA BACTERAEMIA 93 0.0395
55 ATELECTASIS 378 0.0391
56 IMMUNODEFICIENCY 567 0.0380
57 INFUSION SITE PAIN 488 0.0378
58 BLOOD URIC ACID INCREASED 216 0.0374
59 HOSPICE CARE 366 0.0370
60 GANGRENE 223 0.0370
61 CANCER PAIN 94 0.0367
62 INFUSION SITE PRURITUS 116 0.0367
63 INFUSION SITE SWELLING 231 0.0367
64 INFUSION SITE ERYTHEMA 309 0.0366
65 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 185 0.0365
66 TRANSFUSION 377 0.0359
67 INFUSION SITE INFECTION 83 0.0357
68 FAILURE TO THRIVE 185 0.0356
69 ELECTROCARDIOGRAM QT PROLONGED 1259 0.0350
70 MYASTHENIA GRAVIS 278 0.0344
71 CLOSTRIDIUM DIFFICILE COLITIS 357 0.0336
72 TROPONIN INCREASED 249 0.0327
73 HAEMATOLOGICAL INFECTION 80 0.0327
74 AORTIC STENOSIS 112 0.0321
75 SENSORY LOSS 258 0.0320
76 CHRONIC KIDNEY DISEASE 2430 0.0319
77 CARDIOGENIC SHOCK 455 0.0317
78 TYPE I HYPERSENSITIVITY 111 0.0315
79 BLOOD MAGNESIUM DECREASED 272 0.0315
80 RHINOVIRUS INFECTION 120 0.0308
81 HYPOXIA 1083 0.0307
82 HYPOMAGNESAEMIA 417 0.0299
83 PULSELESS ELECTRICAL ACTIVITY 120 0.0287
84 ARTERIAL OCCLUSIVE DISEASE 225 0.0286
85 PSYCHOLOGICAL TRAUMA 246 0.0285
86 HYPERREFLEXIA 99 0.0284
87 IMPAIRED GASTRIC EMPTYING 387 0.0284
88 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 168 0.0283
89 BACTERIAL INFECTION 529 0.0283
90 VENTRICULAR TACHYCARDIA 468 0.0283
91 ASCITES 831 0.0282
92 ENTEROCOLITIS 163 0.0282
93 PRODUCT ADMINISTRATION INTERRUPTED 220 0.0280
94 CARBOHYDRATE ANTIGEN 125 INCREASED 94 0.0275
95 RESPIRATORY SYMPTOM 78 0.0274
96 COELIAC DISEASE 267 0.0272
97 HYDRONEPHROSIS 201 0.0268
98 ATRIAL SEPTAL DEFECT 224 0.0267
99 SMALL INTESTINAL OBSTRUCTION 328 0.0266
100 HEPATIC CYTOLYSIS 338 0.0265
101 BACTERAEMIA 313 0.0263
102 HEMIPLEGIA 219 0.0263
103 NON-CARDIAC CHEST PAIN 83 0.0262
104 UPPER RESPIRATORY TRACT INFECTION 1188 0.0257
105 HYPOKALAEMIA 1186 0.0257
106 STAPHYLOCOCCAL BACTERAEMIA 111 0.0255
107 RED CELL DISTRIBUTION WIDTH INCREASED 106 0.0255
108 TUMOUR LYSIS SYNDROME 224 0.0254
109 TASTE DISORDER 514 0.0253
110 HYPERVOLAEMIA 125 0.0253
111 ENTERITIS 160 0.0250
112 OTITIS MEDIA 82 0.0248
113 PRESCRIBED OVERDOSE 477 0.0246
114 THROMBOCYTOPENIA 2751 0.0246
115 HYPONATRAEMIA 1376 0.0244
116 PROCTALGIA 157 0.0244
117 PULSE ABSENT 116 0.0244
118 BURSITIS 295 0.0243
119 HAIR COLOUR CHANGES 301 0.0242
120 SINUS TACHYCARDIA 342 0.0241
121 ACUTE KIDNEY INJURY 3682 0.0240
122 CONGENITAL ANOMALY 186 0.0240
123 ABDOMINAL TENDERNESS 119 0.0239
124 VENOOCCLUSIVE LIVER DISEASE 118 0.0239
125 PERIPHERAL SENSORY NEUROPATHY 139 0.0238
126 MULTIPLE ORGAN DYSFUNCTION SYNDROME 668 0.0236
127 PATENT DUCTUS ARTERIOSUS 93 0.0234
128 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 89 0.0233
129 INTESTINAL ISCHAEMIA 128 0.0232
130 HYPOVOLAEMIA 136 0.0232
131 CYTOMEGALOVIRUS VIRAEMIA 102 0.0229
132 BREATH SOUNDS ABNORMAL 113 0.0229
133 SEDATION 600 0.0229
134 MOTOR DYSFUNCTION 232 0.0227
135 SINUS CONGESTION 307 0.0227
136 ENCEPHALOPATHY 558 0.0227
137 ARTERIOSPASM CORONARY 91 0.0227
138 RENAL TUBULAR NECROSIS 222 0.0226
139 CONSTIPATION 4901 0.0224
140 ACUTE RESPIRATORY FAILURE 432 0.0224
141 NEUTROPHIL COUNT DECREASED 914 0.0224
142 NEUROPATHY PERIPHERAL 2133 0.0224
143 AFFECT LABILITY 215 0.0223
144 LEFT VENTRICULAR DYSFUNCTION 149 0.0222
145 MALNUTRITION 248 0.0221
146 FULL BLOOD COUNT ABNORMAL 234 0.0221
147 ANHEDONIA 580 0.0220
148 ELECTROLYTE IMBALANCE 254 0.0218
149 FULL BLOOD COUNT DECREASED 439 0.0218
150 VENTRICULAR SEPTAL DEFECT 124 0.0216
151 PROTEIN TOTAL DECREASED 81 0.0215
152 SEPSIS 2399 0.0215
153 MUSCLE SPASTICITY 264 0.0215
154 HAIR DISORDER 176 0.0213
155 BLOOD PHOSPHORUS DECREASED 78 0.0213
156 SEASONAL ALLERGY 302 0.0213
157 METASTASES TO LYMPH NODES 144 0.0213
158 COLITIS 808 0.0213
159 BENIGN PROSTATIC HYPERPLASIA 110 0.0213
160 PANCYTOPENIA 1190 0.0213
161 HYPERBILIRUBINAEMIA 220 0.0212
162 ACUTE PULMONARY OEDEMA 119 0.0212
163 NEURALGIA 511 0.0210
164 DEHYDRATION 2796 0.0209
165 CYTOPENIA 256 0.0209
166 RASH MACULO-PAPULAR 465 0.0209
167 PARONYCHIA 91 0.0207
168 HYPOALBUMINAEMIA 161 0.0207
169 STRESS CARDIOMYOPATHY 120 0.0206
170 RED BLOOD CELL COUNT DECREASED 589 0.0206
171 ORAL CANDIDIASIS 271 0.0206
172 INFUSION RELATED REACTION 1359 0.0205
173 VITAMIN B12 DEFICIENCY 83 0.0205
174 RENAL INJURY 607 0.0204
175 EATING DISORDER 435 0.0204
176 GASTROINTESTINAL MOTILITY DISORDER 109 0.0203
177 TUBULOINTERSTITIAL NEPHRITIS 380 0.0203
178 NEUTROPENIA 2752 0.0202
179 OESOPHAGITIS 221 0.0202
180 TUMOUR MARKER INCREASED 97 0.0202
181 CARDIAC MURMUR 174 0.0201
182 WEIGHT FLUCTUATION 210 0.0201
183 ORAL PAIN 448 0.0200
184 TACHYPNOEA 272 0.0200
185 NEPHROLITHIASIS 917 0.0200
186 HYPERTRANSAMINASAEMIA 139 0.0200
187 HAEMOGLOBIN INCREASED 91 0.0199
188 PLEURAL EFFUSION 1211 0.0199
189 BLOOD CREATINE INCREASED 88 0.0199
190 TOXIC ENCEPHALOPATHY 100 0.0197
191 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 457 0.0196
192 FLANK PAIN 183 0.0195
193 STOMATITIS 1183 0.0195
194 CLOSTRIDIUM DIFFICILE INFECTION 425 0.0195
195 HEMIPARESIS 329 0.0194
196 BLOOD ALBUMIN DECREASED 154 0.0194
197 RESPIRATORY SYNCYTIAL VIRUS INFECTION 169 0.0194
198 LYMPHOPENIA 273 0.0193
199 URINE OUTPUT DECREASED 168 0.0192
200 RESPIRATORY TRACT CONGESTION 305 0.0192
201 CANDIDA INFECTION 324 0.0192
202 BLOOD CALCIUM INCREASED 168 0.0191
203 VOMITING 8995 0.0191
204 APPETITE DISORDER 126 0.0190
205 HYPOPHAGIA 484 0.0189
206 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 103 0.0189
207 TRICUSPID VALVE INCOMPETENCE 150 0.0189
208 HYPERNATRAEMIA 94 0.0188
209 RETCHING 402 0.0188
210 NAUSEA 14912 0.0188
211 UNRESPONSIVE TO STIMULI 486 0.0188
212 OXYGEN SATURATION DECREASED 1057 0.0188
213 MYOCLONUS 223 0.0187
214 LEFT VENTRICULAR HYPERTROPHY 80 0.0187
215 SEPTIC SHOCK 812 0.0186
216 BRAIN FOG 292 0.0186
217 APNOEA 145 0.0186
218 DERMATITIS CONTACT 212 0.0186
219 PLASMA CELL MYELOMA 724 0.0185
220 DEVICE RELATED INFECTION 285 0.0185
221 IMPAIRED QUALITY OF LIFE 266 0.0185
222 WHITE BLOOD CELL COUNT DECREASED 2000 0.0184
223 ODYNOPHAGIA 110 0.0184
224 ILEUS 229 0.0184
225 BLOOD POTASSIUM DECREASED 554 0.0184
226 SUPRAVENTRICULAR TACHYCARDIA 176 0.0184
227 UROSEPSIS 169 0.0183
228 LEUKOPENIA 916 0.0183
229 PLATELET COUNT DECREASED 1948 0.0183
230 BLOOD LACTIC ACID INCREASED 96 0.0182
231 PNEUMOTHORAX 288 0.0181
232 HYPERLIPIDAEMIA 217 0.0181
233 MENTAL STATUS CHANGES 504 0.0181
234 DECREASED APPETITE 4214 0.0181
235 COORDINATION ABNORMAL 253 0.0181
236 LYMPHOCYTE COUNT DECREASED 320 0.0181
237 SKIN HAEMORRHAGE 268 0.0181
238 SINUS DISORDER 358 0.0181
239 BODY TEMPERATURE INCREASED 368 0.0180
240 HAIR TEXTURE ABNORMAL 240 0.0179
241 ASPIRATION 195 0.0178
242 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 168 0.0176
243 LARGE INTESTINE PERFORATION 122 0.0176
244 RHINITIS ALLERGIC 78 0.0175
245 RENAL FAILURE 2318 0.0174
246 BRONCHOSPASM 249 0.0174
247 DERMATITIS ACNEIFORM 106 0.0174
248 NEUROTOXICITY 305 0.0174
249 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 135 0.0174
250 ANAPHYLACTIC REACTION 959 0.0173
251 MADAROSIS 201 0.0173
252 METASTASES TO LIVER 303 0.0172
253 EMBOLISM 143 0.0172
254 TACHYCARDIA 1528 0.0172
255 BLOOD ALKALINE PHOSPHATASE INCREASED 426 0.0171
256 HAEMORRHOIDS 334 0.0171
257 TOXIC EPIDERMAL NECROLYSIS 259 0.0170
258 APHASIA 515 0.0170
259 ANAEMIA 3246 0.0170
260 PRE-EXISTING CONDITION IMPROVED 106 0.0170
261 STAPHYLOCOCCAL SEPSIS 83 0.0168
262 HAEMORRHOIDAL HAEMORRHAGE 82 0.0168
263 HYPERCALCAEMIA 207 0.0167
264 ULCER 266 0.0167
265 ANAL INCONTINENCE 150 0.0167
266 PYREXIA 5748 0.0166
267 BLOOD BILIRUBIN INCREASED 448 0.0166
268 NIGHTMARE 573 0.0165
269 BLOOD SODIUM DECREASED 312 0.0165
270 BLOOD CALCIUM DECREASED 186 0.0165
271 CARDIAC ARREST 1365 0.0165
272 BLOOD TEST ABNORMAL 232 0.0165
273 DISEASE PROGRESSION 1951 0.0165
274 ABDOMINAL PAIN 3832 0.0165
275 ANAPHYLACTIC SHOCK 418 0.0162
276 CHOLECYSTITIS 193 0.0162
277 OROPHARYNGEAL DISCOMFORT 146 0.0161
278 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 277 0.0161
279 CARDIOMEGALY 198 0.0161
280 DYSPNOEA EXERTIONAL 606 0.0161
281 EXPOSURE DURING PREGNANCY 997 0.0160
282 KLEBSIELLA INFECTION 81 0.0160
283 FOETAL GROWTH RESTRICTION 97 0.0159
284 PLATELET COUNT ABNORMAL 96 0.0159
285 FLUID RETENTION 801 0.0157
286 HAEMATOCRIT DECREASED 312 0.0157
287 HICCUPS 129 0.0157
288 FAECALOMA 86 0.0157
289 ORTHOSTATIC HYPOTENSION 273 0.0157
290 METASTASES TO CENTRAL NERVOUS SYSTEM 202 0.0156
291 POOR VENOUS ACCESS 162 0.0156
292 RESPIRATORY DISTRESS 430 0.0156
293 BLOOD CREATININE INCREASED 1016 0.0155
294 HAEMOGLOBIN ABNORMAL 100 0.0155
295 ATRIAL FLUTTER 124 0.0155
296 HYPERHIDROSIS 1998 0.0155
297 TRISMUS 80 0.0155
298 GOUT 277 0.0154
299 COLITIS ISCHAEMIC 104 0.0154
300 DYSTONIA 299 0.0154
301 PERIORBITAL SWELLING 87 0.0154
302 PATHOLOGICAL FRACTURE 78 0.0154
303 CONTRAINDICATED PRODUCT ADMINISTERED 464 0.0153
304 SINUS BRADYCARDIA 148 0.0153
305 PANCREATITIS ACUTE 342 0.0152
306 EJECTION FRACTION DECREASED 236 0.0152
307 DIARRHOEA 9801 0.0152
308 LUNG INFILTRATION 134 0.0152
309 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 155 0.0151
310 PNEUMONITIS 411 0.0151
311 HYPOTENSION 3009 0.0150
312 CYSTITIS 475 0.0149
313 INTESTINAL PERFORATION 167 0.0149
314 ANAL ABSCESS 80 0.0148
315 HAEMATEMESIS 376 0.0148
316 GASTROENTERITIS VIRAL 267 0.0148
317 ACUTE MYELOID LEUKAEMIA 230 0.0147
318 INTESTINAL OBSTRUCTION 556 0.0147
319 LIPASE INCREASED 113 0.0147
320 CELLULITIS 743 0.0147
321 FEEDING DISORDER 298 0.0147
322 HYPOCALCAEMIA 278 0.0147
323 MOUTH ULCERATION 309 0.0147
324 RASH ERYTHEMATOUS 699 0.0146
325 ORAL DISORDER 107 0.0146
326 LEUKOCYTOSIS 264 0.0146
327 ALANINE AMINOTRANSFERASE INCREASED 895 0.0146
328 CYANOSIS 229 0.0145
329 PULMONARY MASS 216 0.0145
330 OSTEOPENIA 220 0.0145
331 COVID-19 PNEUMONIA 171 0.0145
332 DECUBITUS ULCER 118 0.0145
333 MUSCULOSKELETAL CHEST PAIN 224 0.0145
334 DYSARTHRIA 544 0.0144
335 PERICARDIAL EFFUSION 333 0.0144
336 EPISTAXIS 1076 0.0144
337 BRAIN OEDEMA 181 0.0143
338 ASPARTATE AMINOTRANSFERASE INCREASED 757 0.0142
339 GASTROENTERITIS 207 0.0142
340 HEREDITARY ANGIOEDEMA 152 0.0142
341 ESCHERICHIA INFECTION 116 0.0141
342 FLUID OVERLOAD 205 0.0141
343 VENTRICULAR EXTRASYSTOLES 146 0.0140
344 URINARY TRACT INFECTION 2394 0.0140
345 HYPERTHERMIA 107 0.0140
346 HAEMOGLOBIN DECREASED 1436 0.0140
347 PHARYNGITIS 173 0.0139
348 BONE MARROW FAILURE 283 0.0139
349 PULMONARY HYPERTENSION 290 0.0139
350 NEOPLASM PROGRESSION 484 0.0139
351 CHOLECYSTITIS CHRONIC 93 0.0139
352 ACIDOSIS 106 0.0139
353 VITAMIN D DEFICIENCY 135 0.0138
354 INFUSION SITE EXTRAVASATION 86 0.0138
355 PULMONARY EMBOLISM 1308 0.0138
356 IRON DEFICIENCY ANAEMIA 127 0.0137
357 FATIGUE 10694 0.0137
358 INSURANCE ISSUE 210 0.0137
359 SKIN INFECTION 154 0.0137
360 ECONOMIC PROBLEM 208 0.0137
361 FACIAL PAIN 122 0.0137
362 MATERNAL EXPOSURE DURING PREGNANCY 1216 0.0136
363 PREMATURE DELIVERY 217 0.0136
364 UPPER GASTROINTESTINAL HAEMORRHAGE 229 0.0136
365 PETECHIAE 142 0.0136
366 RALES 79 0.0136
367 ACUTE RESPIRATORY DISTRESS SYNDROME 240 0.0136
368 LIVER FUNCTION TEST INCREASED 291 0.0135
369 DECREASED IMMUNE RESPONSIVENESS 133 0.0135
370 ONYCHOCLASIS 93 0.0135
371 GASTROOESOPHAGEAL REFLUX DISEASE 1085 0.0135
372 CARDIO-RESPIRATORY ARREST 563 0.0135
373 GASTROINTESTINAL DISORDER 1205 0.0134
374 POLYNEUROPATHY 161 0.0134
375 POST-TRAUMATIC STRESS DISORDER 90 0.0134
376 PNEUMONIA 4334 0.0134
377 SNEEZING 300 0.0134
378 PRODUCT DISTRIBUTION ISSUE 124 0.0134
379 TRANSAMINASES INCREASED 297 0.0133
380 GENERAL PHYSICAL HEALTH DETERIORATION 1540 0.0133
381 MALIGNANT NEOPLASM PROGRESSION 1362 0.0133
382 DYSPHAGIA 1257 0.0132
383 LOW BIRTH WEIGHT BABY 105 0.0132
384 ABDOMINAL DISTENSION 1379 0.0132
385 GASTRITIS 347 0.0132
386 PAIN IN JAW 372 0.0131
387 RESPIRATORY FAILURE 953 0.0131
388 CHILLS 1530 0.0130
389 ACUTE CORONARY SYNDROME 108 0.0130
390 HEPATOMEGALY 128 0.0130
391 HAEMOPTYSIS 359 0.0129
392 RIGHT VENTRICULAR FAILURE 90 0.0128
393 RESPIRATORY TRACT INFECTION 334 0.0128
394 EAR INFECTION 340 0.0128
395 RESPIRATION ABNORMAL 88 0.0128
396 MULTIPLE ALLERGIES 100 0.0127
397 HEPATIC ENZYME INCREASED 869 0.0127
398 PRODUCTIVE COUGH 607 0.0127
399 AGRANULOCYTOSIS 236 0.0127
400 NEUTROPHIL COUNT INCREASED 130 0.0127
401 GENERALISED OEDEMA 157 0.0127
402 CONCUSSION 98 0.0126
403 NEPHROPATHY TOXIC 142 0.0126
404 NEPHROPATHY 118 0.0126
405 SECOND PRIMARY MALIGNANCY 105 0.0126
406 DIARRHOEA HAEMORRHAGIC 118 0.0126
407 ADRENAL INSUFFICIENCY 153 0.0126
408 GASTROINTESTINAL INFECTION 113 0.0126
409 CARDIOTOXICITY 112 0.0125
410 RHINITIS 101 0.0125
411 ASTHENIA 4710 0.0125
412 MICTURITION URGENCY 143 0.0125
413 METASTASES TO BONE 205 0.0125
414 PSEUDOMONAS INFECTION 107 0.0125
415 METASTASIS 89 0.0125
416 BACK PAIN 2893 0.0124
417 MUSCLE RIGIDITY 148 0.0124
418 MITRAL VALVE INCOMPETENCE 139 0.0123
419 HEPATOCELLULAR INJURY 174 0.0123
420 WEIGHT DECREASED 3423 0.0122
421 HYPOTHERMIA 124 0.0122
422 RESPIRATORY DEPRESSION 150 0.0122
423 SKIN LACERATION 133 0.0122
424 PULMONARY ARTERIAL HYPERTENSION 177 0.0122
425 PULMONARY OEDEMA 545 0.0122
426 PRODUCT DOSE OMISSION IN ERROR 344 0.0121
427 BOWEL MOVEMENT IRREGULARITY 93 0.0121
428 BLOOD IRON DECREASED 144 0.0121
429 TOXIC SKIN ERUPTION 122 0.0121
430 BLOOD COUNT ABNORMAL 183 0.0121
431 C-REACTIVE PROTEIN INCREASED 439 0.0121
432 EXTRASYSTOLES 84 0.0120
433 BONE PAIN 702 0.0120
434 DIZZINESS POSTURAL 116 0.0120
435 SINUSITIS 1222 0.0119
436 CARDIOMYOPATHY 176 0.0119
437 GENERALISED TONIC-CLONIC SEIZURE 197 0.0119
438 FOETAL EXPOSURE DURING PREGNANCY 967 0.0119
439 CHEST DISCOMFORT 1218 0.0119
440 DERMATITIS BULLOUS 86 0.0119
441 ILLNESS 1223 0.0119
442 BLOOD PRESSURE ABNORMAL 236 0.0119
443 SLEEP APNOEA SYNDROME 226 0.0118
444 DRUG INTOLERANCE 1138 0.0118
445 HYPERTENSION 2492 0.0118
446 DRUG INTERACTION 1862 0.0117
447 FUNGAL INFECTION 391 0.0117
448 HAEMOLYTIC ANAEMIA 105 0.0117
449 ANGINA PECTORIS 335 0.0117
450 TOOTH ABSCESS 119 0.0117
451 DYSPHONIA 683 0.0117
452 PYELONEPHRITIS 101 0.0116
453 ANURIA 100 0.0116
454 ELECTROCARDIOGRAM ABNORMAL 91 0.0116
455 INFECTION 1676 0.0116
456 PNEUMONIA BACTERIAL 106 0.0115
457 COUGH 3233 0.0115
458 HIATUS HERNIA 149 0.0115
459 THROMBOSIS 925 0.0115
460 RHINORRHOEA 742 0.0115
461 BLOOD UREA INCREASED 192 0.0115
462 PLATELET COUNT INCREASED 149 0.0114
463 DRY MOUTH 926 0.0114
464 PREMATURE BABY 343 0.0114
465 PALLOR 310 0.0114
466 SPUTUM DISCOLOURED 108 0.0114
467 PULMONARY THROMBOSIS 124 0.0114
468 EAR PAIN 221 0.0114
469 INCONTINENCE 120 0.0113
470 BRONCHOPULMONARY ASPERGILLOSIS 88 0.0113
471 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 85 0.0113
472 FAECES SOFT 82 0.0113
473 SPINAL PAIN 132 0.0113
474 GRAFT VERSUS HOST DISEASE 81 0.0113
475 HEPATOTOXICITY 249 0.0112
476 METASTASES TO LUNG 129 0.0112
477 ATRIAL FIBRILLATION 1087 0.0112
478 DIVERTICULITIS 309 0.0111
479 HEPATIC ENCEPHALOPATHY 104 0.0111
480 POST PROCEDURAL COMPLICATION 214 0.0111
481 BRADYCARDIA 590 0.0111
482 PHOTOPHOBIA 209 0.0111
483 AGEUSIA 277 0.0111
484 GAMMA-GLUTAMYLTRANSFERASE INCREASED 245 0.0110
485 LABORATORY TEST ABNORMAL 326 0.0110
486 BLOOD LACTATE DEHYDROGENASE INCREASED 175 0.0110
487 FLUSHING 1120 0.0110
488 VIRAL INFECTION 366 0.0110
489 LOWER RESPIRATORY TRACT INFECTION 500 0.0110
490 SKIN FISSURES 214 0.0109
491 RIB FRACTURE 225 0.0109
492 CONFUSIONAL STATE 1763 0.0109
493 CHEST PAIN 2020 0.0109
494 DYSPNOEA 6167 0.0109
495 BLOOD PRESSURE INCREASED 1665 0.0109
496 VITAMIN D DECREASED 93 0.0109
497 LIVE BIRTH 91 0.0109
498 APHTHOUS ULCER 84 0.0108
499 URINARY RETENTION 361 0.0108
500 PHARYNGITIS STREPTOCOCCAL 117 0.0108
501 SHOCK HAEMORRHAGIC 88 0.0108
502 KIDNEY INFECTION 211 0.0107
503 DECREASED ACTIVITY 116 0.0107
504 ATAXIA 127 0.0107
505 NEOPLASM 123 0.0107
506 METABOLIC ACIDOSIS 342 0.0107
507 CIRCULATORY COLLAPSE 182 0.0107
508 OROPHARYNGEAL PAIN 989 0.0107
509 ABDOMINAL PAIN LOWER 270 0.0107
510 HYPERGLYCAEMIA 389 0.0107
511 NIGHT SWEATS 343 0.0106
512 GALLBLADDER DISORDER 190 0.0106
513 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 555 0.0106
514 LUNG INFECTION 165 0.0106
515 PNEUMONIA ASPIRATION 265 0.0106
516 DEEP VEIN THROMBOSIS 689 0.0106
517 HAEMATURIA 363 0.0106
518 INJURY 742 0.0105
519 FACE OEDEMA 178 0.0105
520 WHITE BLOOD CELL COUNT INCREASED 404 0.0105
521 ARTHROPOD BITE 78 0.0105
522 CHOLESTASIS 202 0.0105
523 THERAPY INTERRUPTED 748 0.0105
524 GASTROINTESTINAL PAIN 115 0.0104
525 RENAL CYST 83 0.0104
526 CHOLELITHIASIS 342 0.0104
527 EMPHYSEMA 105 0.0104
528 DENTAL CARIES 115 0.0104
529 NECK PAIN 581 0.0104
530 SPINAL OSTEOARTHRITIS 91 0.0103
531 DYSPEPSIA 1019 0.0103
532 BLOOD PRESSURE DECREASED 688 0.0103
533 RESTLESS LEGS SYNDROME 188 0.0103
534 UPPER-AIRWAY COUGH SYNDROME 85 0.0103
535 CONJUNCTIVITIS 191 0.0103
536 HYPERKALAEMIA 361 0.0103
537 MYDRIASIS 132 0.0103
538 MUSCULAR WEAKNESS 1168 0.0103
539 ANXIETY 2920 0.0102
540 PARAESTHESIA ORAL 148 0.0102
541 HYPERSOMNIA 294 0.0102
542 HEART RATE INCREASED 1016 0.0102
543 MYELODYSPLASTIC SYNDROME 148 0.0102
544 MIGRAINE 976 0.0102
545 PHARYNGEAL SWELLING 100 0.0102
546 LETHARGY 588 0.0102
547 DYSURIA 376 0.0102
548 QUALITY OF LIFE DECREASED 137 0.0102
549 FACIAL PARALYSIS 87 0.0102
550 EYE INFECTION 115 0.0102
551 JAUNDICE 274 0.0102
552 OEDEMA PERIPHERAL 1240 0.0102
553 PURPURA 90 0.0102
554 TENDERNESS 106 0.0102
555 RESPIRATORY RATE INCREASED 90 0.0101
556 INFLUENZA 1127 0.0101
557 ABDOMINAL PAIN UPPER 2079 0.0101
558 PRESYNCOPE 244 0.0100
559 OEDEMA 544 0.0100
560 TOOTH INFECTION 132 0.0100
561 LIGAMENT SPRAIN 99 0.0100
562 SPLENOMEGALY 117 0.0100
563 DEVELOPMENTAL DELAY 90 0.0100
564 PANCREATITIS 527 0.0100
565 WOUND INFECTION 109 0.0099
566 GINGIVAL PAIN 79 0.0099
567 PNEUMOCYSTIS JIROVECII PNEUMONIA 99 0.0098
568 NAIL DISORDER 86 0.0098
569 GINGIVAL BLEEDING 134 0.0098
570 GROIN PAIN 86 0.0098
571 NEUROLEPTIC MALIGNANT SYNDROME 116 0.0098
572 JOINT INJURY 208 0.0097
573 LIVER FUNCTION TEST ABNORMAL 283 0.0097
574 SEIZURE 1123 0.0097
575 GASTRIC ULCER 184 0.0097
576 PRODUCT USE IN UNAPPROVED INDICATION 2398 0.0097
577 POLYURIA 79 0.0096
578 FLATULENCE 547 0.0096
579 LIMB INJURY 262 0.0096
580 PERIPHERAL SWELLING 1485 0.0096
581 IMMUNOSUPPRESSION 85 0.0096
582 SYNCOPE 960 0.0096
583 STAPHYLOCOCCAL INFECTION 316 0.0096
584 SLEEP DISORDER 676 0.0096
585 INTENTIONAL DOSE OMISSION 273 0.0096
586 HYPERSENSITIVITY 1775 0.0096
587 ALOPECIA 1877 0.0095
588 DELIRIUM 331 0.0095
589 OFF LABEL USE 8347 0.0095
590 APHONIA 133 0.0095
591 ERYTHEMA 1957 0.0095
592 INTERVERTEBRAL DISC DEGENERATION 88 0.0095
593 THERAPY PARTIAL RESPONDER 148 0.0095
594 HEPATIC FAILURE 286 0.0095
595 BLOOD POTASSIUM INCREASED 154 0.0095
596 HEAD INJURY 299 0.0094
597 PERIPHERAL COLDNESS 129 0.0094
598 DISSEMINATED INTRAVASCULAR COAGULATION 132 0.0094
599 COAGULOPATHY 156 0.0094
600 SUDDEN DEATH 99 0.0093
601 MUSCLE TWITCHING 215 0.0093
602 THROAT TIGHTNESS 252 0.0093
603 FEELING HOT 571 0.0093
604 NOCTURIA 113 0.0093
605 HEADACHE 5827 0.0093
606 THERAPY NON-RESPONDER 417 0.0093
607 ABSCESS 148 0.0093
608 PAIN 5682 0.0092
609 MUSCLE STRAIN 80 0.0092
610 ABDOMINAL DISCOMFORT 1551 0.0092
611 DEPRESSED LEVEL OF CONSCIOUSNESS 365 0.0092
612 TEMPERATURE INTOLERANCE 95 0.0092
613 EMOTIONAL DISTRESS 1114 0.0092
614 FOOT FRACTURE 174 0.0092
615 BRONCHITIS 679 0.0092
616 RASH 3995 0.0092
617 INTENTIONAL PRODUCT MISUSE 802 0.0092
618 ORAL DISCOMFORT 127 0.0091
619 BLOOD PRESSURE SYSTOLIC INCREASED 178 0.0091
620 ASTHMA 1031 0.0091
621 NASAL CONGESTION 536 0.0091
622 RASH PRURITIC 494 0.0091
623 HYPERCHOLESTEROLAEMIA 88 0.0091
624 GLOMERULAR FILTRATION RATE DECREASED 112 0.0091
625 HEPATIC STEATOSIS 169 0.0091
626 COVID-19 1590 0.0091
627 BODY TEMPERATURE DECREASED 89 0.0090
628 BLOOD THYROID STIMULATING HORMONE INCREASED 83 0.0090
629 SKIN ULCER 233 0.0090
630 HOT FLUSH 679 0.0090
631 DYSGEUSIA 664 0.0089
632 SPINAL FRACTURE 179 0.0089
633 LOCALISED INFECTION 216 0.0089
634 MUSCLE SPASMS 1631 0.0089
635 BLOOD PRESSURE FLUCTUATION 213 0.0089
636 BLADDER DISORDER 88 0.0089
637 LYMPHADENOPATHY 313 0.0088
638 PULMONARY CONGESTION 116 0.0088
639 ACUTE HEPATIC FAILURE 120 0.0088
640 INITIAL INSOMNIA 90 0.0088
641 FEELING COLD 242 0.0087
642 URINARY INCONTINENCE 257 0.0087
643 AKATHISIA 118 0.0086
644 THIRST 154 0.0086
645 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 146 0.0086
646 SWELLING 804 0.0086
647 LUNG DISORDER 421 0.0086
648 PROTEINURIA 163 0.0086
649 PARAESTHESIA 1342 0.0085
650 SOMNOLENCE 1717 0.0085
651 MASS 119 0.0085
652 CATARACT 507 0.0085
653 COLD SWEAT 150 0.0085
654 RESTLESSNESS 311 0.0085
655 LOSS OF CONSCIOUSNESS 1086 0.0085
656 RENAL IMPAIRMENT 712 0.0085
657 MYOCARDITIS 97 0.0085
658 TREMOR 1403 0.0084
659 TOOTHACHE 153 0.0084
660 OBSTRUCTIVE AIRWAYS DISORDER 94 0.0084
661 PRODUCT DOSE OMISSION ISSUE 2484 0.0084
662 HAEMORRHAGE INTRACRANIAL 126 0.0084
663 HYPOTHYROIDISM 269 0.0084
664 SCAR 144 0.0084
665 SCIATICA 134 0.0084
666 COMPLICATION ASSOCIATED WITH DEVICE 122 0.0084
667 DYSKINESIA 341 0.0084
668 HYPERTHYROIDISM 121 0.0083
669 PALPITATIONS 976 0.0083
670 CONTUSION 801 0.0083
671 FALL 2767 0.0083
672 FAECES DISCOLOURED 180 0.0083
673 RENAL PAIN 88 0.0083
674 BLISTER 466 0.0083
675 SALIVARY HYPERSECRETION 83 0.0083
676 SARS-COV-2 TEST POSITIVE 109 0.0082
677 HEPATITIS 211 0.0082
678 SPEECH DISORDER 432 0.0082
679 LACRIMATION INCREASED 249 0.0082
680 OSTEOPOROSIS 339 0.0082
681 SKIN EXFOLIATION 695 0.0082
682 ERUCTATION 159 0.0082
683 JOINT SWELLING 991 0.0082
684 DISCOMFORT 500 0.0082
685 PRODUCT USE ISSUE 1540 0.0082
686 RECTAL HAEMORRHAGE 352 0.0082
687 MALAISE 3593 0.0082
688 NODULE 106 0.0081
689 TRANSIENT ISCHAEMIC ATTACK 274 0.0081
690 THROMBOTIC MICROANGIOPATHY 79 0.0081
691 RASH MACULAR 282 0.0081
692 ORAL HERPES 157 0.0080
693 VERTIGO 490 0.0080
694 SPINAL OPERATION 99 0.0080
695 CARDIAC FAILURE 645 0.0080
696 ACCIDENT 95 0.0079
697 RENAL DISORDER 370 0.0079
698 EOSINOPHILIA 139 0.0079
699 WHEEZING 470 0.0079
700 MULTI-ORGAN FAILURE 137 0.0079
701 SKIN LESION 217 0.0079
702 RENAL FAILURE ACUTE 335 0.0079
703 DISORIENTATION 312 0.0079
704 SHOCK 180 0.0078
705 DIZZINESS 3900 0.0078
706 INTENTIONAL PRODUCT USE ISSUE 682 0.0078
707 COLON CANCER 116 0.0078
708 NERVE INJURY 86 0.0077
709 HYPERTENSIVE CRISIS 86 0.0077
710 HOSPITALISATION 1183 0.0077
711 IRRITABLE BOWEL SYNDROME 165 0.0077
712 THERAPY CESSATION 395 0.0077
713 BLOOD URINE PRESENT 146 0.0077
714 DIALYSIS 109 0.0077
715 PERITONITIS 159 0.0077
716 DEVICE OCCLUSION 108 0.0077
717 ACUTE MYOCARDIAL INFARCTION 226 0.0077
718 INFLUENZA LIKE ILLNESS 629 0.0076
719 HEART RATE DECREASED 268 0.0076
720 ANKLE FRACTURE 118 0.0076
721 TOOTH FRACTURE 84 0.0076
722 POOR QUALITY SLEEP 164 0.0076
723 PRODUCT TASTE ABNORMAL 103 0.0076
724 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 364 0.0076
725 WOUND 211 0.0075
726 NASOPHARYNGITIS 1389 0.0075
727 HYPOAESTHESIA 1127 0.0075
728 SWELLING FACE 490 0.0075
729 HEAD DISCOMFORT 133 0.0075
730 FISTULA 84 0.0075
731 SURGERY 437 0.0074
732 SKIN REACTION 105 0.0074
733 RHEUMATOID ARTHRITIS 845 0.0074
734 CHOLECYSTECTOMY 85 0.0074
735 RESPIRATORY ARREST 205 0.0074
736 LIMB DISCOMFORT 230 0.0074
737 DIPLOPIA 193 0.0074
738 SECRETION DISCHARGE 93 0.0074
739 AGITATION 545 0.0074
740 SUBDURAL HAEMATOMA 106 0.0074
741 THYROID DISORDER 114 0.0074
742 HAEMATOCHEZIA 408 0.0074
743 TOOTH DISORDER 164 0.0074
744 FREQUENT BOWEL MOVEMENTS 199 0.0074
745 RASH PAPULAR 165 0.0074
746 BREAST CANCER METASTATIC 79 0.0073
747 ARTHRITIS 576 0.0073
748 MUSCULOSKELETAL DISCOMFORT 126 0.0073
749 RESPIRATORY DISORDER 219 0.0073
750 SKIN DISORDER 244 0.0073
751 SKIN DISCOLOURATION 336 0.0073
752 BALANCE DISORDER 632 0.0073
753 CHROMATURIA 165 0.0073
754 PAIN IN EXTREMITY 2150 0.0073
755 THROAT IRRITATION 326 0.0073
756 PROSTATIC SPECIFIC ANTIGEN INCREASED 100 0.0073
757 GASTRIC DISORDER 249 0.0072
758 HALLUCINATION 544 0.0072
759 DEPRESSION 1642 0.0072
760 GAIT INABILITY 241 0.0072
761 INTERVERTEBRAL DISC PROTRUSION 157 0.0072
762 OSTEOMYELITIS 130 0.0072
763 HEART RATE IRREGULAR 162 0.0072
764 PHOTOSENSITIVITY REACTION 118 0.0071
765 POST PROCEDURAL HAEMORRHAGE 83 0.0071
766 HIP FRACTURE 229 0.0071
767 MYOCARDIAL ISCHAEMIA 81 0.0071
768 PRODUCT USE COMPLAINT 112 0.0071
769 LIVER DISORDER 315 0.0071
770 MIDDLE INSOMNIA 132 0.0071
771 DRUG LEVEL INCREASED 117 0.0071
772 LIP SWELLING 235 0.0070
773 PARALYSIS 101 0.0070
774 OSTEOARTHRITIS 299 0.0070
775 HERPES ZOSTER 402 0.0070
776 DRUG-INDUCED LIVER INJURY 219 0.0070
777 POLLAKIURIA 291 0.0070
778 GASTROINTESTINAL HAEMORRHAGE 580 0.0069
779 DRY SKIN 926 0.0069
780 GLOSSODYNIA 155 0.0069
781 HEPATIC CIRRHOSIS 130 0.0069
782 ANGIOEDEMA 306 0.0069
783 INTERNAL HAEMORRHAGE 79 0.0069
784 WRIST FRACTURE 82 0.0068
785 DERMATITIS ALLERGIC 86 0.0068
786 MYALGIA 1161 0.0068
787 HYPOAESTHESIA ORAL 102 0.0068
788 ARRHYTHMIA 320 0.0068
789 CONDITION AGGRAVATED 2040 0.0067
790 INSOMNIA 1785 0.0067
791 HYPOGLYCAEMIA 324 0.0067
792 PULMONARY FIBROSIS 128 0.0067
793 DEATH 5747 0.0067
794 OBESITY 106 0.0066
795 CARPAL TUNNEL SYNDROME 93 0.0066
796 CORONARY ARTERY DISEASE 201 0.0066
797 BLOOD CHOLESTEROL INCREASED 309 0.0066
798 CEREBRAL HAEMORRHAGE 237 0.0066
799 DRY EYE 330 0.0066
800 CARDIAC FAILURE CONGESTIVE 531 0.0066
801 HAEMATOMA 171 0.0066
802 PRURITUS 2529 0.0066
803 BACK DISORDER 107 0.0066
804 CYTOMEGALOVIRUS INFECTION 109 0.0066
805 GAIT DISTURBANCE 1253 0.0065
806 MELAENA 144 0.0065
807 ARTHRALGIA 2702 0.0065
808 VISION BLURRED 889 0.0065
809 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1165 0.0065
810 DIABETES MELLITUS 492 0.0064
811 PERICARDITIS 108 0.0064
812 MEMORY IMPAIRMENT 883 0.0064
813 HYPOKINESIA 93 0.0064
814 CYST 79 0.0064
815 HERNIA 123 0.0064
816 EYE PAIN 358 0.0063
817 EYE SWELLING 236 0.0063
818 STEVENS-JOHNSON SYNDROME 141 0.0063
819 COGNITIVE DISORDER 296 0.0063
820 HALLUCINATION, VISUAL 133 0.0063
821 IMMUNE SYSTEM DISORDER 83 0.0063
822 INTERNATIONAL NORMALISED RATIO INCREASED 179 0.0063
823 PROCEDURAL PAIN 174 0.0063
824 TOXICITY TO VARIOUS AGENTS 1057 0.0063
825 URTICARIA 1050 0.0063
826 MUSCLE ATROPHY 79 0.0062
827 ROTATOR CUFF SYNDROME 80 0.0062
828 PELVIC PAIN 113 0.0062
829 DIABETIC KETOACIDOSIS 149 0.0062
830 MENTAL DISORDER 269 0.0062
831 MUSCULOSKELETAL PAIN 322 0.0061
832 ALTERED STATE OF CONSCIOUSNESS 133 0.0061
833 PRODUCT PRESCRIBING ISSUE 133 0.0061
834 HUNGER 85 0.0061
835 FIBROMYALGIA 148 0.0061
836 CARDIOVASCULAR DISORDER 154 0.0061
837 DEPRESSED MOOD 320 0.0060
838 PSORIASIS 786 0.0060
839 UPPER LIMB FRACTURE 119 0.0060
840 MYELOSUPPRESSION 214 0.0059
841 MUSCULOSKELETAL STIFFNESS 520 0.0059
842 ISCHAEMIC STROKE 105 0.0059
843 DEAFNESS 153 0.0058
844 MUSCLE TIGHTNESS 94 0.0058
845 DYSSTASIA 169 0.0058
846 INTERSTITIAL LUNG DISEASE 278 0.0057
847 PANIC ATTACK 209 0.0057
848 JOINT STIFFNESS 150 0.0057
849 SWOLLEN TONGUE 178 0.0057
850 IMPAIRED HEALING 187 0.0057
851 WEIGHT INCREASED 1266 0.0056
852 BONE DISORDER 103 0.0056
853 BURNING SENSATION 396 0.0056
854 HAEMORRHAGE 585 0.0056
855 ADVERSE DRUG REACTION 502 0.0056
856 AMNESIA 361 0.0055
857 DELUSION 86 0.0055
858 FEELING ABNORMAL 1324 0.0055
859 MOBILITY DECREASED 396 0.0055
860 FEELING JITTERY 103 0.0054
861 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 139 0.0054
862 DERMATITIS 113 0.0054
863 PSYCHOMOTOR HYPERACTIVITY 89 0.0054
864 TINNITUS 246 0.0053
865 NEOPLASM MALIGNANT 357 0.0053
866 TREATMENT FAILURE 442 0.0053
867 RASH GENERALISED 137 0.0053
868 DRUG WITHDRAWAL SYNDROME NEONATAL 78 0.0053
869 CEREBROVASCULAR ACCIDENT 891 0.0053
870 PRODUCT AVAILABILITY ISSUE 119 0.0052
871 NERVOUS SYSTEM DISORDER 163 0.0052
872 ACCIDENTAL OVERDOSE 191 0.0052
873 VISUAL IMPAIRMENT 645 0.0052
874 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 285 0.0052
875 LOWER LIMB FRACTURE 99 0.0051
876 INFLAMMATION 265 0.0051
877 TOOTH LOSS 106 0.0051
878 PRODUCT PRESCRIBING ERROR 121 0.0051
879 BONE DENSITY DECREASED 159 0.0051
880 CHOKING 99 0.0051
881 ECZEMA 265 0.0051
882 SENSORY DISTURBANCE 81 0.0050
883 PRODUCT ADMINISTRATION ERROR 102 0.0050
884 MULTIPLE FRACTURES 82 0.0050
885 INCREASED APPETITE 95 0.0050
886 ILL-DEFINED DISORDER 299 0.0049
887 BLOOD GLUCOSE DECREASED 236 0.0049
888 COMA 234 0.0049
889 EMOTIONAL DISORDER 151 0.0049
890 MOVEMENT DISORDER 157 0.0049
891 PRODUCT DOSE OMISSION 319 0.0049
892 RHABDOMYOLYSIS 202 0.0048
893 CARDIAC DISORDER 452 0.0048
894 ROAD TRAFFIC ACCIDENT 202 0.0048
895 BLOOD CREATINE PHOSPHOKINASE INCREASED 139 0.0048
896 LIVER INJURY 118 0.0048
897 IMPAIRED WORK ABILITY 100 0.0047
898 DISTURBANCE IN ATTENTION 252 0.0047
899 EYE PRURITUS 156 0.0046
900 DRUG ERUPTION 82 0.0046
901 DISABILITY 91 0.0046
902 UNEVALUABLE EVENT 348 0.0046
903 HYPOACUSIS 198 0.0046
904 PAIN OF SKIN 122 0.0045
905 COMPLETED SUICIDE 376 0.0045
906 HEPATIC FUNCTION ABNORMAL 165 0.0044
907 NERVOUSNESS 228 0.0044
908 LACTIC ACIDOSIS 141 0.0043
909 TREATMENT NONCOMPLIANCE 238 0.0043
910 EXTRAPYRAMIDAL DISORDER 108 0.0043
911 SKIN CANCER 93 0.0043
912 EPILEPSY 132 0.0043
913 MENTAL IMPAIRMENT 104 0.0043
914 VAGINAL HAEMORRHAGE 185 0.0043
915 PRESCRIBED UNDERDOSE 84 0.0042
916 PSORIATIC ARTHROPATHY 170 0.0042
917 COLITIS ULCERATIVE 186 0.0042
918 PANCREATIC CARCINOMA 118 0.0041
919 OCULAR HYPERAEMIA 193 0.0041
920 OVERDOSE 868 0.0040
921 CONVULSION 229 0.0040
922 ARTHROPATHY 217 0.0039
923 KNEE ARTHROPLASTY 82 0.0039
924 IRRITABILITY 233 0.0039
925 SUICIDAL IDEATION 354 0.0039
926 ABNORMAL BEHAVIOUR 153 0.0039
927 CRYING 139 0.0038
928 THERAPEUTIC PRODUCT EFFECT DECREASED 170 0.0038
929 BLINDNESS 154 0.0038
930 PSYCHOTIC DISORDER 111 0.0038
931 DERMATITIS ATOPIC 195 0.0037
932 EYE DISORDER 121 0.0037
933 THERAPEUTIC RESPONSE UNEXPECTED 163 0.0036
934 DRUG INEFFECTIVE 4786 0.0036
935 MOOD ALTERED 99 0.0036
936 THERAPEUTIC RESPONSE SHORTENED 120 0.0036
937 FEMUR FRACTURE 112 0.0036
938 SYSTEMIC LUPUS ERYTHEMATOSUS 124 0.0035
939 UNDERDOSE 254 0.0035
940 LUNG NEOPLASM MALIGNANT 142 0.0035
941 DEVICE DISLOCATION 150 0.0034
942 EYE IRRITATION 197 0.0034
943 ADVERSE EVENT 315 0.0034
944 BLOOD GLUCOSE INCREASED 639 0.0034
945 FEAR 91 0.0034
946 OSTEONECROSIS OF JAW 82 0.0033
947 INTENTIONAL OVERDOSE 212 0.0033
948 OSTEONECROSIS 108 0.0033
949 DEMENTIA 91 0.0033
950 CEREBRAL INFARCTION 79 0.0032
951 GASTRIC CANCER 81 0.0032
952 NEEDLE ISSUE 92 0.0032
953 SUICIDE ATTEMPT 191 0.0031
954 TYPE 2 DIABETES MELLITUS 105 0.0031
955 MEDICATION ERROR 171 0.0031
956 INJECTION SITE RASH 92 0.0030
957 MOOD SWINGS 95 0.0030
958 ACNE 225 0.0030
959 MULTIPLE SCLEROSIS RELAPSE 203 0.0030
960 MYOCARDIAL INFARCTION 502 0.0029
961 WITHDRAWAL SYNDROME 120 0.0029
962 THERAPEUTIC RESPONSE DECREASED 171 0.0028
963 INJECTION SITE MASS 102 0.0028
964 AGGRESSION 138 0.0028
965 ANGER 91 0.0027
966 DISEASE RECURRENCE 128 0.0027
967 INJECTION SITE BRUISING 213 0.0027
968 INJECTION SITE REACTION 183 0.0027
969 INCORRECT DOSE ADMINISTERED 606 0.0027
970 SKIN IRRITATION 117 0.0026
971 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 172 0.0024
972 INJECTION SITE PRURITUS 161 0.0024
973 MULTIPLE SCLEROSIS 114 0.0024
974 INJECTION SITE ERYTHEMA 292 0.0024
975 DEVICE ISSUE 211 0.0024
976 INJECTION SITE PAIN 701 0.0023
977 DRUG DOSE OMISSION 376 0.0023
978 EXTRA DOSE ADMINISTERED 92 0.0023
979 DRUG EFFECT INCOMPLETE 81 0.0022
980 DEVICE LEAKAGE 95 0.0022
981 INJECTION SITE SWELLING 161 0.0021
982 DRUG WITHDRAWAL SYNDROME 184 0.0021
983 ABORTION SPONTANEOUS 83 0.0021
984 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 413 0.0020
985 BREAST CANCER 182 0.0020
986 SKIN BURNING SENSATION 138 0.0019
987 DEVICE MALFUNCTION 126 0.0018
988 INJECTION SITE HAEMORRHAGE 137 0.0017
989 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 121 0.0017
990 NO ADVERSE EVENT 306 0.0017
991 PRODUCT QUALITY ISSUE 219 0.0016
992 PRODUCT STORAGE ERROR 131 0.0015
993 DRUG ABUSE 121 0.0015
994 ACCIDENTAL EXPOSURE TO PRODUCT 134 0.0013
995 DRUG DEPENDENCE 166 0.0010